Source credit: PubMed / Journal of the International Society of Sports Nutrition – Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis.
Summary: A 2026 systematic review and meta-analysis in the Journal of the International Society of Sports Nutrition evaluated randomized trials of creatine monohydrate in postmenopausal women. Across seven trials, the review found small but meaningful improvements in lean mass and leg-press strength, especially when creatine at 5 grams per day or more was paired with resistance training, while bone-density changes were not clearly improved.
Why it matters for lifters
- This is a useful masters-lifting data point: The paper adds more support for creatine as a practical supplement option for women focused on strength, muscle retention, and training quality after menopause.
- Training still appears to be the anchor: The clearer benefits showed up when creatine was combined with resistance training, not treated like a stand-alone shortcut.
- Bone claims still need restraint: The review did not show a clear overall bone-density benefit, so lifters should not oversell creatine as a bone-health fix based on this evidence set.
What to watch next
- Watch for longer trials that standardize creatine dose, training structure, and menopause status more tightly.
- Watch whether future studies confirm which lifters respond best, especially around training age, dietary protein intake, and baseline muscle mass.
- If you are considering creatine, use product quality, dose, hydration, and your own medical context as part of the decision instead of treating social-media anecdotes like evidence.
Health disclaimer: This article is for informational purposes only and is not medical advice. Supplement decisions should be individualized with qualified medical guidance, especially if you have kidney disease, take prescription medications, or have other health concerns.